-
Sulfo-NHS-SS-Biotin: A Reversible Surface Workflow
2026-09-04
Sulfo-NHS-SS-Biotin combines aqueous compatibility with a cleavable disulfide linker for controlled protein labeling and surface-proteome analysis. This guide focuses on assay decisions, causal controls, and how to interpret cell-surface findings without mistaking protein labeling for direct glycoRNA detection.
-
Angiotensin 1/2 (5-7): Assay Reliability Guide
2026-09-04
This scenario-driven guide explains how Angiotensin 1/2 (5-7), SKU A1049, can support reproducible renin-angiotensin system, viability, proliferation, and binding workflows. It connects defined peptide identity, 98.36% HPLC and mass-spectrometry purity, solvent options, and storage guidance with practical experimental controls.
-
GDC-0994: Selective ERK1/2 Inhibitor Guide
2026-09-03
GDC-0994 is a potent, selective ERK1/2 inhibitor for studying MAP kinase signaling in cancer and hepatic models. Its nanomolar biochemical potency, oral bioavailability, and reported activity in mutant RAS/BRAF xenografts support research use, while zebrafish evidence connects ERK1/2 inhibition with protection from phytoestrogen-associated cholestatic injury.
-
Ginsenosides Protect Lung and Kidney Under Hypoxia
2026-09-03
Ji et al. investigated how ginsenosides protect rat lung and kidney tissues during simulated high-altitude hypoxia, combining physiological, histological, molecular, and fluorescence-based analyses. The study links tissue protection with modulation of the PHD2/HIF-1α/EPO axis, while also identifying reductions in oxidative stress, inflammation, blood abnormalities, and hypoxia-associated tissue injury.
-
HyperFluor™ 488 Rabbit Anti-Goat IgG (H+L) Antibody
2026-09-02
Use this Alexa Fluor 488 conjugated secondary antibody to convert goat-primary workflows into bright, multiplex-ready readouts across immunofluorescence, Western blotting, flow cytometry, and tissue staining. Its affinity purification, H+L-chain recognition, and defined storage formulation make it particularly useful for imaging host–virus organization, including FXR-associated replication-organelle clustering.
-
Baicalin: Reliable Cell Assay Workflows
2026-09-02
Learn how Baicalin (SKU N1778) can improve experimental consistency in cell viability, proliferation, and cytotoxicity workflows through controlled solubilization, vehicle matching, and orthogonal data interpretation. The article connects KEAP1-NRF2/HO-1 pathway modulation and TGF-β1/p-Smad3 pathway inhibition with practical assay design and product-selection decisions.
-
Salvianolic Acid B Targets LH2 in Pulmonary Fibrosis
2026-09-01
The reference study identifies Salvianolic acid B as a natural compound that reduces lysyl hydroxylase 2 expression, collagen cross-linking, and fibrotic remodeling in pulmonary fibrosis models. Its integrated cellular, molecular, and tissue-level evidence positions LH2 as a mechanistically relevant target while highlighting the need for further dose, target-engagement, and translational studies.
-
Oridonin Protects Bone Through MAPK/NF-κB and BMP-2/RUNX2
2026-08-31
The 2023 reference study identifies oridonin as a dual-action osteoprotective candidate in a thioacetamide-induced bone injury model. Its central finding is that oridonin suppresses osteoclast differentiation through MAPK/NF-κB and ROS-related mechanisms while restoring osteogenic differentiation through the BMP-2/RUNX2 axis.
-
Shh–Fgf10–Fgfr2 Control Penile Development
2026-08-31
Wang and Zheng identify differential Shh, Fgf10, and Fgfr2 expression as a developmental explanation for why guinea pigs form an open urethral groove whereas mice primarily canalize a urethral plate. By combining comparative gene-expression analysis with genital-tubercle culture experiments, the study links species-specific signaling intensity to preputial timing and urethral morphogenesis, while also clarifying the value and limits of guinea pigs as a model for human development.
-
NHS-Biotin for Multimeric Protein Assays
2026-08-30
NHS-Biotin enables reliable amine-reactive labeling for protein detection, purification, and intracellular studies. This guide explains how to use biotinylation as an assay-design and interpretation layer alongside modern nanobody multimerization strategies.
-
HyperFluor™ 488: Smarter Antibody Assays
2026-08-29
The HyperFluor 488 Goat Anti-Human IgG (H+L) Antibody enables sensitive human IgG detection across fluorescence-based assays. This guide connects its molecular design to vaccine-immunology workflows, species controls, and practical assay decisions.
-
Perospirone: Receptor and Kv1.5 Research
2026-08-29
Perospirone (SM-9018 free base) supports both receptor-centered schizophrenia research and mechanistic studies of vascular Kv1.5 inhibition. This workflow connects high-affinity serotonergic and dopaminergic pharmacology with a concentration-dependent, use-independent ion-channel effect while emphasizing solvent control, assay separation, and translational limits.
-
Angiotensin I/II (1-5) Protocol Guide
2026-08-28
Angiotensin I/II (1-5) provides a defined Asp-Arg-Val-Tyr-Ile peptide fragment for controlled renin-angiotensin system workflows involving blood pressure and aldosterone-related endpoints. It is appropriate for cardiovascular, renal, and hypertension research, but should not be treated as a broadly applicable peptide signal or assigned assay potency without direct validation.
-
HyperFluor™ 488 Rabbit Anti-Goat IgG (H+L) Antibody
2026-08-28
A scenario-based guide to using HyperFluor™ 488 Rabbit Anti-Goat IgG (H+L) Antibody, SKU K1214, in immunofluorescence, Western blotting, tissue staining, flow cytometry, and ELISA. It explains controls, optical settings, storage, optimization, and interpretation when viability or cytotoxicity assays need an orthogonal protein-level readout.
-
Mono-ADP-Ribosylation as a Degradation Signal
2026-08-27
The reference study shows that blocking ubiquitylation or proteasomal turnover exposes endogenous ADP-ribosylated proteins that are otherwise rapidly degraded. It identifies DTX2 as the E3 ligase that removes PARP7, AHR, and other PARP7 substrates, establishing mono-ADP-ribosylation as a functional degradation mark in AHR signaling.